Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of beta-blockers and other cardiovascular drugs. Its enantiomeric purity is critical for achieving desired biological activity in active pharmaceutical ingredients. Commonly employed in asymmetric synthesis routes where the (S)-configuration ensures optimal binding to target receptors. Also utilized in the preparation of enzyme inhibitors and in medicinal chemistry research for structure-activity relationship studies.